Royalty Pharma provide holders with the opportunity to achieve liquidity for their interests and alleviate the concentration risk of owning a single-product royalty. Royalty owners benefit from the ability to monetize a passive asset and enhanced individual estate and tax planning.

Royalty Pharma provides holders with the opportunity to achieve liquidity for their interests and reduce the concentration risk of owning a single-product royalty. In addition, the sale of a royalty may permit royalty owners to monetize a passive financial asset and optimize individual estate and tax planning.

Companies who work with Royalty Parma enjoy financial flexibility with greater bandwidth and more aggressive timelines with less “red tape” than traditional financing alternatives.